Skip to main content

$0.295 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
2 July 2025 at 3:00pm
Register to track PAL and receive email alerts.
Subject
PAL Ann: Removal from Official List

PAL Ann: Update to Shareholders - Voluntary Delisting from ASX

PAL Ann: Update to Shareholders

PAL Ann: Update to Shareholders - Declaration of shares as worthless

PAL Ann: Update to Shareholders

PAL Ann: Update to shareholders

PAL Ann: Update to Shareholders

PAL Ann: Update to shareholders

PAL Ann: Update to shareholders

PAL Ann: Update to shareholders

PAL Ann: Update to Shareholders

PAL Ann: Update to Shareholders

PAL Ann: Update to shareholders

PAL Ann: Palla Pharma enters Voluntary Administration

PAL Ann: Voluntary Suspension

PAL Ann: Trading Halt

PAL Ann: Response to ASX Price Query

PAL Ann: Sale and Leaseback of Coolaroo Site

PAL Ann: Jobkeeper Payments Notice

PAL Ann: Resignation and appointment of Chief Financial Officer

PAL Ann: Investor Update Presentation Conference Call Recording

PAL Ann: Investor Update

PAL Ann: Interim Financial Report - 30 June 2021

PAL Ann: Half Year Results and Investor Update Conference Call

PAL Ann: Update on lodgement of reviewed half-year financial report

PAL Ann: Extension of Reporting Deadline for Interim Financial Report

PAL Ann: Appendix 4D & Preliminary Interim Report - 30 June 2021

PAL Ann: Revised Half Year Reporting Timetable & Results Presentation

PAL Ann: Half Year Results Presentation and Investor Conference Call

PAL Ann: European Co-Codamol submissions completed

PAL Ann: Appointment of Alloga widening UK distribution network

PAL Ann: Interactive recording and presentation of the 2021 AGM

PAL Ann: Results of Annual General Meeting

PAL Ann: 2021 Annual General Meeting Presentation

PAL Ann: Palla Pharma Limited announces new CEO, Mr Giles Moss

PAL Ann: AGM to be held virtually due to COVID-19 restrictions

PAL Ann: PAL Formal Product Launch & Production Partnership Update

PAL Ann: Notice of Annual General Meeting/Proxy Form

PAL Ann: Change of Director's Interest Notice - I. Ross

PAL Ann: Change of Director's Interest Notice

PAL Ann: Change of Director's Interest Notice

PAL Ann: Appendix 2A

PAL Ann: Appendix 2A update

PAL Ann: Palla Pharma successfully completes Retail Entitlement Offer

PAL Ann: Palla Pharma 2020 Corporate Governance Statement

PAL Ann: Palla Pharma 2020 Appendix 4G

PAL Ann: Palla Pharma Annual Report

PAL Ann: First Palla Pharma 30/500 Co-Codamol Caplet Order

PAL Ann: Investor Update

PAL Ann: Retail Entitlement Offer Booklet

Register to track PAL and receive email alerts.

Similar Companies

ADO
BPH
CTE
GSS
GTG
MEM
OSL
PIQ